We compiled 104 constitutional de novo or sporadic rearranged chromosomes mimicking recombinants from a parental pericentric inversion in order to comment on their occurrence and parental derivation, meiotic or postzygotic origin, mean parental ages, and underlying pathways. Chromosomes involved were 1-9, 13-18, 20-22, and X (64 autosomes and 40 X chromosomes). In the whole series, mean paternal and maternal ages in cases of paternal (proved or possible; n = 29) or maternal (proved or possible; n = 36) descent were 31.14 and 28.31 years, respectively. Rearranged X chromosomes appeared to be of paternal descent and to arise through intrachromosomal non-allelic homologous recombination (NAHR), whereas rec-like autosomes were of either maternal or paternal origin and resulted from mechanisms proper of non-recurrent rearrangements. Except for some mosaic cases, most rearranged chromosomes apparently had a meiotic origin. Except for 8 rearranged X chromosomes transmitted maternally, all other cases compiled here were sporadic. Hence, the recurrence risk for sibs of propositi born to euploid parents is virtually zero, regardless of the imbalance's size. In brief, recombinant-like or rea chromosomes are not related to advanced parental age, may (chromosome X) or may not (autosomes) have a parent-of-origin bias, arise in meiosis or postzygotically, and appear to be mediated by NAHR, nonhomologous end joining, and telomere transposition. Because rearranged chromosomes 10, 11, and Y are also on record, albeit just in abstracts or listed in large series, we remark that all chromosomes can undergo this distinct rearrangement, even if it is still to be described for pairs 12 and 19.

Keywords:
Cytogenetic nomenclature, de novo, Genomic disorders, Rearranged chromosomes, Recombinant-like chromosomes
1.
Ballif BC, Wakui K, Gajecka M, Shaffer LG: Translocation breakpoint mapping and sequence analysis in three monosomy 1p36 subjects with der(1)t(1;1)(p36;q44) suggest mechanisms for telomere capture in stabilizing de novo terminal rearrangements. Hum Genet 114:198-206 (2004).
2.
Bryan J, McGaughran J: De novo recombinant chromosome 11 with partial monosomy 11q25-ter and partial trisomy 11p15.1-ter; first case report and discussion of the underlying mechanism. 11th International Congress of Human Genetics, Brisbane, Australia (2006).
3.
D'Angelo CS, Gajecka M, Kim CA, Gentles AJ, Glotzbach CD, et al: Further delineation of nonhomologous-based recombination and evidence for subtelomeric segmental duplications in 1p36 rearrangements. Hum Genet 125:551-563 (2009).
4.
Daniel A, Baker E, Chia N, Haan E, Malafiej P, et al: Recombinants of intrachromosomal transposition of subtelomeres in chromosomes 1 and 2: a cause of minute terminal chromosomal imbalances. Am J Med Genet A 117A:57-64 (2003).
5.
Domínguez MG, Arteaga-Alcaraz G, Rivera H: Pure duplication 21q21.2→qter due to a rea(21) in a Down syndrome girl. Remarks on nomenclature. Genet Couns 23:311-316 (2012).
6.
Giglio S, Pirola B, Arrigo G, Dagrada P, Bardoni B, et al: Opposite deletions/duplications of the X chromosome: two novel reciprocal rearrangements. Eur J Hum Genet 8:63-70 (2000).
7.
Goodman BK, Shaffer LG, Rutberg J, Leppert M, Harum K, et al: Inherited duplication Xq27-qter at Xp22.3 in severely affected males: molecular cytogenetic evaluation and clinical description in three unrelated families. Am J Med Genet 80:377-384 (1998).
8.
Gu W, Zhang F, Lupski JR: Mechanisms for human genomic rearrangements. PathoGenetics 1:4 (2008).
9.
Hecht F, Grix A Jr, Hecht BK, Berger C, Bixenman H, et al: Direct prenatal chromosome diagnosis of a malignancy. Cancer Genet Cytogenet 11:107-111 (1984).
10.
ISCN (2013): An International System for Human Cytogenetic Nomenclature, Shaffer LG, McGowan-Jordan J, Schmid M (eds) (S. Karger, Basel 2013).
11.
Kim HJ, Hsu LY, Hirschhorn K: Familial X/X translocation: t(X;X)(p22;q13). Cytogenet Cell Genet 13:454-464 (1974).
12.
Lupski JR: Genomic rearrangements and sporadic disease. Nat Genet 39(Suppl 7):S43-S47 (2007).
13.
Lyle R, Prandini P, Osoegawa K, Hallers B, Humphray S, et al: Islands of euchromatin-like sequence and expressed polymorphic sequences within the short arm of human chromosome 21. Genome Res 17:1690-1696 (2007).
14.
Madariaga ML, Rivera H: Familial inv(X)(p22q22): ovarian dysgenesis in two sisters with del Xq and fertility in one male carrier. Clin Genet 52:180-183 (1997).
15.
Ogata T, Matsuo N, Fukushima Y, Saito M, Nose O, et al: FISH analysis for apparently simple terminal deletions of the X chromosome: identification of hidden structural abnormalities. Am J Med Genet 104:307-311 (2001).
16.
Paskulin GA, Zen PR, Rosa RF, Manique RC, Cotter PD: Report of a child with a complete de novo 17p duplication localized to the terminal region of the long arm of chromosome 17. Am J Med Genet A 143A:1366-1370 (2007).
17.
Ravnan JB, Tepperberg JH, Papenhausen P, Lamb AN, Hedrick J, et al: Subtelomere FISH analysis of 11688 cases: an evaluation of the frequency and pattern of subtelomere rearrangements in individuals with developmental disabilities. J Med Genet 43:478-489 (2006).
18.
Sibbons C, Morris JK, Crolla JA, Jacobs PA, Thomas NS: De novo deletions and duplications detected by array CGH: a study of parental origin in relation to mechanisms of formation and size of imbalance. Eur J Hum Genet 20:155-160 (2012).
19.
Syrrou M, Borghgraef M, Fryns JP: Unusual chromosomal mosaicism in Wolf-Hirschhorn syndrome: del(4)(p16)/der(4)(qter-q31.3:: pter-qter). Am J Med Genet 104:199-203 (2001).
20.
Thomas NS, Durkie M, Van Zyl B, Sanford R, Potts G, et al: Parental and chromosomal origin of unbalanced de novo structural chromosome abnormalities in man. Hum Genet 119:444-450 (2006).
21.
Vasquez AI, Rivera H, Bobadilla L, Crolla JA: A familial Xp+ chromosome, dup (Xq26.3→ qter). J Med Genet 32:891-893 (1995).
22.
Vasquez-Velásquez AI, Torres-Flores J, Leal CA, Rivera H: Apparent neotelomere in a 46,X,del(X)(qter→p11.2:)/46,X,rea(X)(qter→p11.2::q21.2→qter) novel mosaicism: review of 34 females with a recombinant-like dup(Xq) chromosome. Genet Test Mol Biomarkers 15:727-731 (2011).
23.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.